Moreover, NR2C2 protein expression level was up-regulated in glioma cells compared with NHAs (P < 0.05), and also in glioma tissues compared with NBTs (Fig. 3c, P < 0.05). This evidence concerns the gene NR2C2 and central nervous system cancer.